Citation Impact

Citing Papers

Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
2014
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Linking functional decline of telomeres, mitochondria and stem cells during ageing
2010 Nature
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation meets cancer, with NF-κB as the matchmaker
2011
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Imaging the Glycosylation State of Cell Surface Glycoproteins by Two‐Photon Fluorescence Lifetime Imaging Microscopy
2013 StandoutNobel
Shared Principles in NF-κB Signaling
2008 Standout
Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control
2015
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
2012
Hallmarks of aging: An expanding universe
2023 Standout
The role of myeloid cells in the promotion of tumour angiogenesis
2008
An IKKα–E2F1–BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence
2013
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Differentiation and function of Foxp3+ effector regulatory T cells
2012
Integrins in prostate cancer progression
2008
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Genetic determinants of cancer metastasis
2007
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Mitochondria: In Sickness and in Health
2012 Standout
Tumor metastasis: moving new biological insights into the clinic
2013
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
2008 Nature
Basic principles of tumor-associated regulatory T cell biology
2012
Inflammation and Colon Cancer
2010 Standout
Suppression of lung adenocarcinoma progression by Nkx2-1
2011 Nature
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Clonal Expansion of Early to Mid-Life Mitochondrial DNA Point Mutations Drives Mitochondrial Dysfunction during Human Ageing
2014
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
2010 Nature
Immunity, Inflammation, and Cancer
2010 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Accumulating Mitochondrial DNA Mutations Drive Premature Hematopoietic Aging Phenotypes Distinct from Physiological Stem Cell Aging
2011
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
2010 Nature
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
The diverse and complex roles of NF-κB subunits in cancer
2012
Crosstalk in NF-κB signaling pathways
2011 Standout
The Hallmarks of Aging
2013 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
2012
Metastatic colonization by circulating tumour cells
2016 StandoutNature
NF-κB signaling in cancer stem cells: a promising therapeutic target?
2015
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Cancer-related inflammation
2008 StandoutNature
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
2016
Frailty in elderly people
2013 Standout
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
2010
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
2015 Nature
A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα
2010 StandoutNobel
Roles of regulatory T cells in cancer immunity
2016
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
The NF-κB Pathway and Cancer Stem Cells
2016
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Somatic Progenitor Cell Vulnerability to Mitochondrial DNA Mutagenesis Underlies Progeroid Phenotypes in Polg Mutator Mice
2012
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
2016
Metabolic reprogramming and cancer progression
2020 StandoutScience
New photosensitizers for photodynamic therapy
2016 Standout
Immunity, inflammation, and cancer: an eternal fight between good and evil
2015
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
NF‐κB and the link between inflammation and cancer
2012
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel

Works of Wei Phin Tan being referenced

Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
2007 Nature
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
2011 Nature
A NIK-IKKα Module Expands ErbB2-Induced Tumor-Initiating Cells by Stimulating Nuclear Export of p27/Kip1
2013
Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction
2009
Photodynamic therapy with 3‐(1′‐hexyloxyethyl) pyropheophorbide‐a for early‐stage cancer of the larynx: Phase Ib study
2015
MC0553: A phase II safety and efficacy study with the VEGF receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer.
2011
Rankless by CCL
2026